Equity (Details Textual) - USD ($) $ / shares in Units, $ in Thousands |
1 Months Ended |
12 Months Ended |
|
|
|
|
Dec. 31, 2017 |
Jan. 31, 2017 |
Oct. 31, 2015 |
Sep. 30, 2015 |
Mar. 31, 2014 |
Nov. 28, 2013 |
Dec. 31, 2017 |
Dec. 31, 2016 |
May 31, 2018 |
Mar. 13, 2018 |
Mar. 09, 2018 |
Dec. 03, 2015 |
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares |
|
|
|
|
|
|
|
|
400,000
|
3,333,336
|
|
|
Ordinary shares issued |
|
|
|
|
|
|
|
|
|
|
982,344
|
|
2013 Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Description of option agreement |
|
|
|
|
|
Under the 2013 Plan, the Company may grant its officers, directors, employees and consultants, Stock options, of the Company. Each Stock option granted shall be exercisable at such times and terms and conditions as the Board of Directors may specify in the applicable option agreement, provided that no option will be granted with a term in excess of 10 years.
|
|
|
|
|
|
|
Reserved for issuance shares of common stock |
|
|
|
|
|
1,000,000
|
|
|
|
|
|
|
Series 7 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Registered warrants |
|
|
|
|
9,907,500
|
|
|
|
|
|
|
|
Warrants were exercisable into ordinary shares |
|
|
|
|
396,300
|
|
|
|
|
|
|
|
Recorded amount of share premium |
|
|
|
|
$ 258
|
|
|
|
|
|
|
|
Series 10 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Registered warrants |
|
|
|
|
|
|
39,042,000
|
|
|
|
|
|
Warrants were exercisable into ordinary shares |
|
|
|
|
|
|
1,561,680
|
|
|
|
|
|
Warrants expired date |
|
|
|
|
|
|
Oct. 31, 2017
|
|
|
|
|
|
Fair value of warrants |
|
|
|
|
|
|
$ 240
|
$ 146
|
|
|
|
|
Changes in fair value of warrants from commitment date |
|
|
|
|
|
|
Dec. 31, 2017
|
|
|
|
|
|
Series 11 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Registered warrants |
|
|
|
|
|
|
37,372,500
|
|
|
|
|
|
Warrants were exercisable into ordinary shares |
|
|
|
|
|
|
1,494,900
|
|
|
|
|
|
Warrants expired date |
|
|
|
|
|
|
Oct. 31, 2017
|
|
|
|
|
|
Fair value of warrants |
|
|
|
|
|
|
$ 307
|
126
|
|
|
|
|
Changes in fair value of warrants from commitment date |
|
|
|
|
|
|
Dec. 31, 2017
|
|
|
|
|
|
Series 12 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Registered warrants |
|
|
|
|
|
|
1,470,000
|
|
|
|
|
|
Warrants were exercisable into ordinary shares |
|
|
|
|
|
|
1,470,000
|
|
|
|
|
|
Warrants expired date |
|
|
|
|
|
|
Oct. 31, 2017
|
|
|
|
|
|
Fair value of warrants |
|
|
|
|
|
|
$ 303
|
$ 291
|
|
|
|
|
Changes in fair value of warrants from commitment date |
|
|
|
|
|
|
Dec. 31, 2017
|
|
|
|
|
|
September 2015 Financing [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase shares issued |
|
|
|
|
|
|
2,275,863
|
|
|
|
|
|
Cash issuance costs |
|
|
|
|
|
|
$ 789
|
|
|
|
|
|
October 2015 Financing [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase shares issued |
|
|
|
|
|
|
998,276
|
|
|
|
|
|
Cash issuance costs |
|
|
|
|
|
|
$ 525
|
|
|
|
|
|
ADS [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares |
138,890
|
|
|
|
|
|
138,890
|
|
|
|
|
|
Additional ordinary shares |
69,445
|
|
|
|
|
|
|
|
|
|
|
|
ADS [Member] | Placement Agent Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares |
|
250,000
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase shares issued |
|
125,000
|
|
|
|
|
|
|
|
|
|
|
Fair value of warrants issued |
|
$ 1,868
|
|
|
|
|
|
|
|
|
|
|
Cash issuance costs |
|
621
|
|
|
|
|
|
|
|
|
|
|
Additional issuance costs |
|
$ 188
|
|
|
|
|
|
|
|
|
|
|
Warrants exercise price |
|
$ 2.25
|
|
|
|
|
|
|
|
|
|
|
ADS [Member] | September 2015 Financing [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable price per share |
$ 5.25
|
|
|
|
|
|
$ 5.25
|
|
|
|
|
|
Equivalent to ordinary share price per share |
2.625
|
|
|
|
|
|
$ 2.625
|
|
|
|
|
|
Fair value of warrants issued |
|
|
|
|
|
|
$ 3,167
|
|
|
|
|
|
Warrants term |
|
|
|
|
|
|
five and a half years
|
|
|
|
|
|
ADS [Member] | October 2015 Financing [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable price per share |
5.25
|
|
|
|
|
|
$ 5.25
|
|
|
|
|
|
Equivalent to ordinary share price per share |
2.625
|
|
|
|
|
|
$ 2.625
|
|
|
|
|
|
Fair value of warrants issued |
|
|
|
|
|
|
$ 147
|
|
|
|
|
|
ADS [Member] | March 2014 Financing [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable price per share |
6.43
|
|
|
|
|
|
$ 6.43
|
|
|
|
|
|
Equivalent to ordinary share price per share |
3.215
|
|
|
|
|
|
$ 3.215
|
|
|
|
|
|
Fair value of warrants issued |
|
|
|
|
|
|
$ 1,098
|
|
|
|
|
|
Warrants term |
|
|
|
|
|
|
Four years
|
|
|
|
|
|
ADS [Member] | December 2014 Financing [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable price per share |
4.45
|
|
|
|
|
|
$ 4.45
|
|
|
|
|
|
Equivalent to ordinary share price per share |
$ 2.225
|
|
|
|
|
|
$ 2.225
|
|
|
|
|
|
Fair value of warrants issued |
|
|
|
|
|
|
$ 1,535
|
|
|
|
|
|
Warrants term |
|
|
|
|
|
|
Five years
|
|
|
|
|
|
Placement Agent Warrants [Member] | ADS [Member] | September 2015 Financing [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase shares issued |
|
|
|
|
|
|
103,448
|
|
|
|
|
|
Ordinary shares issued |
206,897
|
|
|
|
|
|
206,897
|
|
|
|
|
|
Exercisable price per share |
$ 5.25
|
|
|
|
|
|
$ 5.25
|
|
|
|
|
|
Equivalent to ordinary share price per share |
$ 2.625
|
|
|
|
|
|
$ 2.625
|
|
|
|
|
|
Subject to certain adjustments, for a period |
|
|
|
|
|
|
5 years
|
|
|
|
|
|
Cash issuance costs |
|
|
|
|
|
|
$ 317
|
|
|
|
|
|
Placement Agent Warrants [Member] | ADS [Member] | October 2015 Financing [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase shares issued |
|
|
|
|
|
|
55,460
|
|
|
|
|
|
Ordinary shares issued |
110,920
|
|
|
|
|
|
110,920
|
|
|
|
|
|
Exercisable price per share |
$ 5.25
|
|
|
|
|
|
$ 5.25
|
|
|
|
|
|
Equivalent to ordinary share price per share |
$ 2.625
|
|
|
|
|
|
$ 2.625
|
|
|
|
|
|
Subject to certain adjustments, for a period |
|
|
|
|
|
|
4 years
|
|
|
|
|
|
Fair value of warrants issued |
|
|
|
|
|
|
$ 143
|
|
|
|
|
|
Direct Offering [Member] | ADS [Member] | September 2015 Financing [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares |
|
|
|
2,068,966
|
|
|
|
|
|
|
|
|
Additional ordinary shares |
|
|
|
2,068,966
|
|
|
|
|
|
|
|
|
Gross proceeds |
|
|
|
$ 9,000
|
|
|
|
|
|
|
|
|
Issued unregistered warrants to purchase |
|
|
|
1,034,483
|
|
|
|
|
|
|
|
|
Ordinary shares issued |
|
|
|
4,137,932
|
|
|
|
|
|
|
|
|
Direct Offering [Member] | ADS [Member] | October 2015 Financing [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares |
|
|
1,109,196
|
|
|
|
|
|
|
|
|
|
Additional ordinary shares |
|
|
887,356
|
|
|
|
|
|
|
|
|
|
Gross proceeds |
|
|
$ 4,825
|
|
|
|
|
|
|
|
|
|
Issued unregistered warrants to purchase |
|
|
443,678
|
|
|
|
|
|
|
|
|
|
Ordinary shares issued |
|
|
2,218,392
|
|
|
|
|
|
|
|
|
|
Certain institutional and accredited investors [Member] | ADS [Member] | January 2017 Financing [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Sold an aggregate shares |
|
2,500,000
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares |
|
5,000,000
|
|
|
|
|
|
|
|
|
|
|
Warrants to purchase additional shares |
|
1,250,000
|
|
|
|
|
|
|
|
|
|
|
Additional ordinary shares |
|
2,500,000
|
|
|
|
|
|
|
|
|
|
|
Aggregate purchase price |
|
$ 5,000
|
|
|
|
|
|
|
|
|
|
|
Warrants term |
|
five and a half years
|
|
|
|
|
|
|
|
|
|
|
Warrants exercise price |
|
$ 2.25
|
|
|
|
|
|
|
|
|
|
|
NIS [Member] | 2013 Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares par value |
|
|
|
|
|
$ 0.25
|
|
|
|
|
|
|
NIS [Member] | Series 10 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Warrants exercise price |
|
|
|
|
|
|
$ 9.85
|
|
|
|
|
|
NIS [Member] | Series 11 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Warrants exercise price |
|
|
|
|
|
|
9.80
|
|
|
|
|
|
NIS [Member] | Series 12 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Warrants exercise price |
|
|
|
|
|
|
15.29
|
|
|
|
|
|
NIS [Member] | January 2017 Financing [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Subject to certain adjustments, for a period |
1868
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary Shares [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares par value |
$ 0.25
|
|
|
|
|
|
$ 0.25
|
$ 0.25
|
|
|
|
|
Number of shares authorized |
80,000,000
|
|
|
|
|
|
80,000,000
|
80,000,000
|
|
|
|
|
Ordinary Shares [Member] | NIS [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
Statement Line Items [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary shares par value |
|
|
|
|
|
|
|
|
|
|
|
$ 0.25
|
Authorized share capital |
|
|
|
|
|
|
|
|
|
|
|
$ 10,000
|
Increased authorized share capital |
|
|
|
|
|
|
|
|
|
|
|
$ 20,000
|
Number of shares authorized |
|
|
|
|
|
|
|
|
|
|
|
80,000,000
|